Open Access

Therapeutic effects of rapamycin on alcoholic cardiomyopathy

  • Authors:
    • Xilin Tu
    • Chao Wang
    • Xiaoxue Ru
    • Lili Jing
    • Lijun Zhou
    • Ling Jing
  • View Affiliations

  • Published online on: August 8, 2017     https://doi.org/10.3892/etm.2017.4901
  • Pages: 2763-2770
  • Copyright: © Tu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study aimed to investigate whether rapamycin has therapeutic potential as a treatment for alcoholic cardiomyopathy. Rats were divided into eight groups (n=7 in each group): The control group; the alcohol group; abstinence in the first week; abstinence in the third week; abstinence in the fourth week; abstinent+rapamycin (AB‑RAP) until the first week (AB‑RAP 1); AB‑RAP until the third week (AB‑RAP 3); and AB‑RAP until the fourth week (AB‑RAP 4). Subsequently, echocardiography, and hematoxylin‑eosin and Masson's staining were performed, followed by electron microscopy and terminal deoxynucleotidyl transferase‑mediated dUTP nick‑end labeling assay. Finally, expression levels of B cell lymphoma‑2, Beclin‑1 and microtubule‑associated protein 1A/1B‑light chain 3 were detected by immunohistochemistry and western blot analysis. The levels of left ventricular end‑diastolic dimension in AB‑RAP 3 (7.00±0.41) and AB‑RAP 4 (6.33±0.68) groups were significantly lower when compared with the alcohol group (8.01±0.30; P<0.05). Compared with the alcohol group, the apoptosis rate of left ventricular myocardial tissue in the AB+RAP 3 (37.68±2.15) and AB+RAP 4 (26.97±2.11) groups was significantly reduced (P<0.05). To conclude, rapamycin may be considered as a therapeutic tool to attenuate alcoholic cardiomyopathy and improve cardiac function through increasing autophagy and reducing apoptosis.

Related Articles

Journal Cover

October-2017
Volume 14 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Tu X, Wang C, Ru X, Jing L, Zhou L and Jing L: Therapeutic effects of rapamycin on alcoholic cardiomyopathy. Exp Ther Med 14: 2763-2770, 2017
APA
Tu, X., Wang, C., Ru, X., Jing, L., Zhou, L., & Jing, L. (2017). Therapeutic effects of rapamycin on alcoholic cardiomyopathy. Experimental and Therapeutic Medicine, 14, 2763-2770. https://doi.org/10.3892/etm.2017.4901
MLA
Tu, X., Wang, C., Ru, X., Jing, L., Zhou, L., Jing, L."Therapeutic effects of rapamycin on alcoholic cardiomyopathy". Experimental and Therapeutic Medicine 14.4 (2017): 2763-2770.
Chicago
Tu, X., Wang, C., Ru, X., Jing, L., Zhou, L., Jing, L."Therapeutic effects of rapamycin on alcoholic cardiomyopathy". Experimental and Therapeutic Medicine 14, no. 4 (2017): 2763-2770. https://doi.org/10.3892/etm.2017.4901